Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/fbef2433-2cb7-42f9-b281-4e20aabb3204/

FONR

Fonar Corporation
Chart
$19.09
Latest Week 2026-06-05
HealthcareDiagnostics & ResearchMICRO
Snapshot 2026-06-07 · 0.0w · Fresh
0.84
OS Score
89.0%
Value
16.0%
Quality
76.0%
Momentum
5/9
F-Score
0.377
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
4 of 23 passing
★
OS Composite
OS 0.840
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
19.9%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 30%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
Val 89th
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
89.0%ile
P/E
18.0×
P/S
1.1×
P/B
0.7×
E/P
0.0557
FCF Yield
0.151
EBITDA/EV
0.199
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
16.00000000
/100 — 1=cheapest
VC2 (Trending Value)
22.00000000
/100
VC3 (Buyback)
22.00000000
/100
FCF yield of 15.1% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
16.0%ile
ROE
0.037
ROA
0.031
Net Margin
0.064
Op Margin
0.090
GPA
0.193
D/E
0.31
Current
9.18
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.023
Earn Growth
-0.207
Stability
0.430
lower=better
Accruals
-0.004
lower=better
5yr Consist
No
Conservative balance sheet with D/E of 0.31.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
76.0%ile
6M Return
30.7%
12M Return
31.8%
12-1 Mom
30.1%
Risk-Adj
0.94
Vol 252d
31.9%
Vol 60d
77.5%
↑ Expanding
Max DD 12M
-12.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 30% is very strong — a clear uptrend. Near-term vol (78%) is expanding vs long-term (32%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.84
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
95.6%
Sector Quality %ile
4.8%
P/E z-score
-0.14
P/B z-score
-0.36
Sector Avg OS
63.2%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Trending Value Signal
Cheap (89th value) with strong momentum (76th). The market is starting to recognise the value.
Cheap for a Reason?
Looks cheap (89th value) but weak quality (16th). Classic value trap risk.
Volatility Expanding
60-day vol (78%) significantly exceeds 252-day (32%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
73.0% avg (7 factors)
Quality
C
49.6% avg (8 factors)
Momentum
B
66.7% avg (4 factors)
Risk
B
63.5% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.840—1—
Value %ile0.890—1—
Quality %ile0.160—1—
Momentum %ile0.760—1—
F-Score5.000—0—
Confidence1.000—1—
Volatility0.319—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
17.97
Earnings Yield (E/P)
0.0557
Price / Sales
1.14
Price / Book
0.67
Price / Cash Flow
15.84
FCF Yield
15.1%
EBITDA / EV
19.9%
Sales Yield (1/P·S)
1.4926
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
3.7%
Return on Assets
3.1%
Net Margin
6.4%
Operating Margin
9.0%
Gross Profit / Assets
Novy-Marx GPA
19.3%
Debt / Equity
0.31
Current Ratio
9.18
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.004
MomentumPrice trend strength over different horizons
6M Return
30.7%
12M Return
31.8%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
30.1%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.94
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
2.3%
Earnings Growth (YoY)
-20.7%
Earnings Stability (CV)
Lower = more stable
0.430
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
16
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
22
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
22
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity